Lucy Pike
Overview
Explore the profile of Lucy Pike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adjogatse D, Michaelidou A, Sanchez Nieto B, Kozarski R, Sassoon I, Evans M, et al.
Radiother Oncol
. 2023 Mar;
183:109645.
PMID: 36997123
No abstract available.
2.
Georgi T, Kurch L, Hasenclever D, Warbey V, Pike L, Radford J, et al.
PLoS One
. 2023 Mar;
18(3):e0283694.
PMID: 36976821
Introduction: Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study...
3.
Matheoud R, Boellaard R, Pike L, Ptacek J, Reynes-Llompart G, Soret M, et al.
Phys Med
. 2022 Dec;
105:102506.
PMID: 36538846
This article presents the protocol on Quality Controls in PET/CT and PET/MRI published online in May 2022 by the European Federation of Organisations for Medical Physics (EFOMP), which was developed...
4.
Szyszko T, Dunn J, Phillips M, Bomalaski J, Sheaff M, Ellis S, et al.
JTO Clin Res Rep
. 2022 Sep;
3(9):100382.
PMID: 36082278
Introduction: Pegargiminase (ADI-PEG 20I) degrades arginine in patients with argininosuccinate synthetase 1-deficient malignant pleural mesothelioma (MPM) and NSCLC. Imaging with proliferation biomarker 3'-deoxy-3'-[F] fluorothymidine (F-FLT) positron emission tomography (PET)-computed tomography...
5.
Reynes-Llompart G, Zorz A, Boellaard R, Ptacek J, Pike L, Soret M, et al.
Phys Med
. 2022 May;
99:16-21.
PMID: 35598481
Purpose: An EFOMP Working Group (WG) was created in 2020 to establish recommendations for PET/CT/MRI Quality Control (QC). The WG's intention was to create a document containing a set of...
6.
Gilbert F, Harris S, Miles K, Weir-McCall J, Qureshi N, Rintoul R, et al.
Health Technol Assess
. 2022 Mar;
26(17):1-180.
PMID: 35289267
Background: Current pathways recommend positron emission tomography-computerised tomography for the characterisation of solitary pulmonary nodules. Dynamic contrast-enhanced computerised tomography may be a more cost-effective approach. Objectives: To determine the diagnostic...
7.
Gilbert F, Harris S, Miles K, Weir-McCall J, Qureshi N, Rintoul R, et al.
Thorax
. 2021 Dec;
77(10):988-996.
PMID: 34887348
Introduction: Dynamic contrast-enhanced CT (DCE-CT) and positron emission tomography/CT (PET/CT) have a high reported accuracy for the diagnosis of malignancy in solitary pulmonary nodules (SPNs). The aim of this study...
8.
Gould S, MacKewn J, Chicklore S, Cook G, Mallia A, Pike L
EJNMMI Phys
. 2021 Jul;
8(1):58.
PMID: 34331602
Background: A significant proportion of the radiation dose from a PET-CT examination is dependent on the CT protocol, which should be optimised for clinical purposes. Matching protocols on different scanners...
9.
Rogasch J, Boellaard R, Pike L, Borchmann P, Johnson P, Wolf J, et al.
Eur J Nucl Med Mol Imaging
. 2021 May;
48(9):2696-2710.
PMID: 33990846
No abstract available.
10.
Boughdad S, OConnor A, Cook G, Pike L, Connor S, Obholzer R, et al.
Clin Endocrinol (Oxf)
. 2021 Feb;
95(2):315-322.
PMID: 33598922
Methods: Clinical data on genetic testing and follow-up were collected for patients who had FDG PET-CT scans from 2004 to 2016. Receiver operator characteristic (ROC) analysis was used to compare...